Interactions Between Two or More Firms
All of the strategies presented in chapter 3 presented actions of originator companies to stave off generic and parallel trade competition were performed only by the originator producer. In all these cases no competitor actively participated in deterrence of competition and restricting consumers’ access to alternative products. Even if deterring competition is imposed for the originator manufacturer to realize higher prices and profits, cooperation between competitors can also lead to extended exclusivity rights of the branded drug manufacturer.
KeywordsEurope Marketing Testosterone Fentanyl Settling
Unable to display preview. Download preview PDF.